Topcare Headache PM Formula

Product NDC
36800-355
11-digit product format
368000355
Labeler code
36800
Product ID
36800-355_c0337d33-a5de-4045-be54-dd4c66b8b7e8
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Diphenhydramine HCl
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Topco Associates LLC
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
1997-08-25
Marketing end
2021-02-28
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
Active strength
500 mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct36800-355DDiscontinued by firm2026-10-12
excluded packagepackage36800-35536800-355-71DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage36800-355-71d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage36800-355-71f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage36800-355-712ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage36800-355-71a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage36800-355-71cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage36800-355-71cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage36800-355-71302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage36800-355-71ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage36800-355-710efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage36800-355-71ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage36800-355-71367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage36800-355-71557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
36800-355-71EA - Each36800-35572645904-bfd8-4a45-99fa-d82ea72875a812012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
DIPHENHYDRAMINE HYDROCHLORIDEACTIVE INGREDIENTTC2D6JAD40TOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
ACETAMINOPHENACTIVE MOIETY362O9ITL9DTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
DIPHENHYDRAMINEACTIVE MOIETY8GTS82S83MTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
CROSPOVIDONEINACTIVE INGREDIENT68401960MKTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30TOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ATOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8HTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
POVIDONESINACTIVE INGREDIENTFZ989GH94ETOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPTOPCARE HEADACHE PM FORMULA (ACETAMINOPHEN, DIPHENHYDRAMINE HCL) TABLET, FILM COATED [TOPCO ASSOCIATES LLC]3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
36800-355-71368000355711 BOTTLE in 1 CARTON (36800-355-71) > 50 TABLET, FILM COATED in 1 BOTTLE1 bottle1997-08-252021-02-28NoNoCurrent